GXP CONSULTING Switzerland Revenue and Competitors

Lausanne, Switzerland

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • GXP CONSULTING Switzerland's estimated annual revenue is currently $10.5M per year.(i)
  • GXP CONSULTING Switzerland's estimated revenue per employee is $201,000

Employee Data

  • GXP CONSULTING Switzerland has 52 Employees.(i)
  • GXP CONSULTING Switzerland grew their employee count by 2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M522%N/AN/A
#2
$155.6M7747%N/AN/A
#3
$40.8M20310%N/AN/A
#4
$245.6M1222-24%N/AN/A
#5
$142.3M7080%N/AN/A
#6
$141.1M702-9%N/AN/A
#7
$16.7M8328%N/AN/A
#8
$16.5M828%N/AN/A
#9
$21.3M10615%N/AN/A
#10
$13.7M68-1%N/AN/A
Add Company

What Is GXP CONSULTING Switzerland?

Are you passioned about the Life Sciences? Are you ready to make a difference? Do you feel excited about the opportunity to collaborate and share your expertise with our industry leaders? YES? SO DO WE! GXP CONSULTING Switzerland is a swiss consulting company with a passioned team of Life Sciences professionals. Since 2014 we deliver outstanding industry's expertise and support to our clients in the complete range of product life cycle in the following areas: Quality Assurance, Qualification/Validation, Regulatory Affairs, Operational Excellence, Engineering, Manufacturing and Maintenance and Project Management. Learn more about us by visiting our webpage www.gxp-cs.com

keywords:N/A

N/A

Total Funding

52

Number of Employees

$10.5M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GXP CONSULTING Switzerland News

2022-04-06 - Genedata Expressionist® 16.0 Provides Enhanced In-Depth Characterization and GxP Compliance Capabilities

BASEL, Switzerland (PRWEB) April 11, 2022 ... of quality monitoring processes, this release also provides new GxP-compliance capabilities.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.7M538%N/A
#2
N/A548%N/A
#3
N/A5438%N/A
#4
$6.9M5525%N/A
#5
$16M55-30%N/A